Placental inflammation and perinatal transmission of HIV-1

Journal of Acquired Immune Deficiency Syndromes

Volumn 29, Issue 3, 2002, Pages 262-269

  Mwanyumba, Fabian ^a   Galliard, Philippe ^a   Inion, Ingrid ^a   Verhofstede, Chris ^a   Claeys, Patricia ^a   Chohan, Varsha ^a   Vansteelandt, Stijn ^a   Mandaliya, Kishorchandra ^a   Praet, Marleen ^a   Temmerman, Marleen ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

HIV 1; Mother to child transmission (MTCT) risk factors; Placental inflammation

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; ARTICLE; CHORIOAMNIONITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FETUS; HISTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFECTION RISK; KENYA; MAJOR CLINICAL STUDY; PERINATAL INFECTION; PLACENTA DISORDER; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SEROPREVALENCE; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 0036499954     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200203010-00006     Document Type: Article

References (37)

1. Prevention of mother-to-child transmission of HIV-1 in Africa
2. Prevention of mother-to-child HIV transmission in resource-poor countries: Translating research into policy and practice
3. Detection of maternofetal transfusion by placental alkaline phosphatase levels
4. Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission
5. Detection of HIV DNA in cervical and vaginal secretions
6. Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: Association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency
7. HIV-1 detection in cervicovaginal secretions during pregnancy
8. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1. A meta-analysis of 15 prospective cohort studies
9. High risk of HIV-1 infection for first-born twins
10. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother-to-child
11. The association between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d'Ivoire
12. Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulceration
13. Treatment of cervicitis is associated with decreased cervical shedding of HIV-1
14. Infection of the placenta
15. Exposure to HIV-1 during delivery and mother-to-child transmission
16. Risk factors for mother-to-child transmission of human immunodeficiency virus-1 infection
17. Chorioamnionitis and pregnancy outcome in HIV-infected African women
18. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine
19. The Ariel Project: A prospective cohort study of maternal-child transmission of human immunodeficiency virus type 1 in the era of maternal antiretroviral therapy
20. Placental membrane inflammation and risks of maternal-to-child transmission of HIV-1 in Uganda
21. Placental abnormalities associated with human immunodeficiency virus type 1 infection and perinatal transmission in Bangkok, Thailand
22. Vaginal lavage with chlorhexidine during labor to reduce mother-to-child HIV transmission: Clinical trial in Mombasa, Kenya
23. Standardisation of primers and an algorithm for HIV-1 diagnostic PCR evaluated in patients harbouring strains of diverse geographical origin
24. Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1
25. Maximum likelihood estimation of the attributable fraction from logistic models
26. Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand
27. Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors
28. Interaction between timing of perinatal human immunodeficiency virus and the design of preventive and therapeutic interventions
29. An assessment of the timing of mother-to-child transmission of human immunodeficiency virus type 1 by means of polymerase chain reaction
30. Perinatal intervention trial in Africa: Effect of a birth canal cleansing intervention to prevent HIV transmission
31. Maternal viral loads and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand
32. Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast-feeding population in Kinshasa, Zaire
33. Mass antimicrobial treatment in pregnancy. A randomized, placebo-controlled trial in a population with high rates of sexually transmitted diseases
34. Antimicrobial prophylaxis in pregnancy: A randomized, placebo-controlled trial with cefetamet-pivoxil in pregnant women with a poor obstetric history
35. Permeation of human chorioamniotic membranes by Escherichia coli in vitro
36. HIV-1 in the female genital tract and the effect of antiretroviral therapy